The value of health in a cost-effectiveness analysis: theory vs practice

Pharmacoeconomics

Apr 19

Written By Matthijs Versteegh

Methods

Matthijs Versteegh

Societal Utilities for Cognitive Impairment in Schizophrenia: Developing a Preference-Based Scoring Algorithm Based on the Schizophrenia Cognition Rating Scale

The economics of patents and innovation in pharma